"ROI Media adds an entirely new dimension to Vestiage." - Scott Kimball, CEO
Newport Beach, California (PRWEB) November 07, 2013
Vestiage, Inc. (stock symbol "VEST"), a publicly traded anti-aging lifestyle company focused on science-based premium branded highly potent anti-aging cosmeceuticals and nutraceuticals, announced today that it has engaged ROI Media for direct to consumer advertising. ROI Media is known for its award-winning radio and television campaigns for multiple major brands. (http://www.ROImediadirect.com)
"At this stage of our growth, it is time for us to engage the best people in the business to drive sales through multiple channels," said Scott Kimball, CEO of Vestiage. "ROI has proven repeatedly that they can drive major successes in the direct response and customer acquisition channels such as radio and television. Clearly these are terrifically talented pros that add a whole new dimension to Vestiage."
Since the formation of Vestiage, the Company has stated that its model would be to sell products through multiple channels. In 2014 the Company will have multiple brands entering several channels including retail, internet, and now, with the engagement of ROI Media, the Company will be moving the appropriate products into the direct to consumer channel. This will also serve to support the Company's retail oriented marketing and advertising.
"We take on very few new clients, but we see Vestiage as the emerging leader in their space. Clearly there is no shortage of nutraceutical companies, but Vestiage is taking the industry to a new level. Their research and focus on products based upon human stem cells is the difference maker, and we're proud to have been chosen as their advertising agency," said Zeus Peleuses, President of ROI Media Direct.
Vestiage has an active growth plan in place calling for the creation and acquisition of several anti-aging brands over the next 3-5 years. The acquisition program supports and accelerates the Company's organic growth plan. The Vestiage R&D program has resulted in the discovery and/or use of certain patented botanical and marine ingredients, which are then used in novel combinations within its brands. Ingredient research and development, as well as formulations, are done in conjunction with large industry partners and laboratories assisting in the development of internally created brands. The Company's Mergers and Acquisitions team reviews potential acquisition targets regularly. The Company recently completed the acquisition of the RegiMEN mens anti-aging system of supplements. Vestiage will launch the female anti-aging line Monterey Bay Nutraceuticals in January 2014 with production giant Robinson Pharma and botanical ingredient company Nutragenesis. The line is designed to address the key issues in high demand for women over 40.
About Vestiage, Inc.
Vestiage (stock symbol "VEST") is a publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and ingredients to produce highly potent, elegantly formulated products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through RegiMEN supplements and Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com). Vestiage brands address the top “in demand” anti-aging concerns of men and women. Vestiage research is focused on longevity and human performance science that covers both the cognitive and physical realms. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across brands. To learn more, visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.